| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATXN8 opposite strand lncRNA | 0.650 | 0.423 |
|
phenotype | 0.100 | None | 1.000 | 13 | 0 | 1997 | 2019 | |||||||||
|
ATP synthase F0 subunit 6 | 0.541 | 0.731 |
|
phenotype | 0.170 | None | 0.875 | 7 | 0 | 2007 | 2019 | |||||||||
|
Cbl proto-oncogene like 2 | 0.476 | 0.808 |
|
phenotype | 0.030 | None | 1.000 | 3 | 0 | 2016 | 2019 | |||||||||
|
competing endogenous lncRNA 3 for miR-645 | 0.531 | 0.808 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2018 | |||||||||
|
chromosome 20 open reading frame 181 | 0.479 | 0.885 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
microRNA 3191 | 0.931 | 0.077 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
spinocerebellar ataxia 37 | 0.931 | 0.115 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||
|
FMR1 intronic transcript 1 | 0.716 | 0.385 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
H3 histone pseudogene 28 | 0.553 | 0.692 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
Hashimoto thyroiditis | 0.505 | 0.731 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
fragile site, folic acid type, rare, fra(X)(q27.3) A (macroorchidism, mental retardation) | 0.641 | 0.462 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
spinocerebellar ataxia 26 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||||
|
X-ray repair cross complementing 6 pseudogene 5 | 0.579 | 0.769 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
phenotype | 0.110 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
NADH dehydrogenase, subunit 4 (complex I) | 0.546 | 0.769 |
|
phenotype | 0.110 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
tRNA | 0.647 | 0.692 |
|
phenotype | 0.110 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||
|
ribonuclease A family member 2 | 0.621 | 0.692 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1989 | 1989 | |||||||||
|
spinocerebellar ataxia 18 (sensory with neurogenic muscular atrophy) |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||||
|
spectrin repeat containing nuclear envelope protein 1 | 0.511 | 0.846 | 3.2E-52 |
|
phenotype | 0.100 | None | 1.000 | 11 | 0 | 2007 | 2019 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
phenotype | 0.200 | None | 1.000 | 14 | 0 | 1998 | 2020 | ||||||||
|
SPG11 vesicle trafficking associated, spatacsin | 0.576 | 0.538 | 1.6E-39 |
|
phenotype | 0.110 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
NLR family pyrin domain containing 2 | 0.515 | 0.731 | 1.4E-38 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
SPG7 matrix AAA peptidase subunit, paraplegin | 0.436 | 0.885 | 2.0E-36 |
|
phenotype | 0.150 | None | 1.000 | 5 | 1 | 2009 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily A member 1 | 0.546 | 0.846 | 7.2E-35 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
sterile alpha motif domain containing 9 | 0.606 | 0.808 | 1.1E-33 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 |